公司资料

Immix Biopharma 股价、新闻与催化剂

股票代码:: IMMX
交易所:: NASDAQ
行业:: Biopharma
所在地:: United States

股票表现

11.34 USD (+3.37%)

收盘价

最后更新: 2026年8月17日

596M USD

市值

股价为何变动

As of Aug 17, 2026, IMMX closed up 3.37% at $11.34. No new same-company headline was identified in the current news window.

公司概览

业务概览

Immix Biopharma is a biotechnology company focused on immune-driven therapies and oncology programs. Its strategy centers on translating immune biology into targeted treatment options.

所在地与行业分类

Headquartered in the United States and listed on NASDAQ, Immix sits in specialty biotechnology.

商业模式特征

The company depends on clinical data, platform validation, and the ability to build a differentiated cancer story.

生物医药行业定位

Immix is a catalyst-sensitive biotech name whose stock depends on early clinical progress.

未来催化剂

Immix’s catalysts are the oncology and immunology pipeline, especially any update that shows the company can still generate a clearer clinical path. The story remains early and data-dependent.